...
首页> 外文期刊>Materials science & engineering >Self-assembled micellar clusters based on Triton-X-family surfactants for enhanced solubilization, encapsulation, proteins permeability control, and anticancer drug delivery
【24h】

Self-assembled micellar clusters based on Triton-X-family surfactants for enhanced solubilization, encapsulation, proteins permeability control, and anticancer drug delivery

机译:基于Triton-X系列表面活性剂的自组装胶束簇,可增强溶解性,包封性,蛋白质通透性控制和抗癌药物递送

获取原文
获取原文并翻译 | 示例

摘要

Non-ionic surfactants have raised a considerable interest for solubilization, encapsulation, permeabilization and controlled release of various compounds due to their unique physicochemical properties. Nevertheless, it is still challenging to create convenient self-assembled multifunctional materials with high solubilization and encapsulation capacities by preserving their advanced capabilities to protect loaded cargos without altering their characteristics. In this work, we present an extended concept of micellar clusters (MCs) formation based on partial entrapment and stabilization of chelate ligands by hydrophobic forces found on the non-ionic surfactant micelle interface of the Triton-X family (TX-100/TX-114), followed by subsequent complexation of the preformed structures either by metal ions or a supporting chelator. The formation aspects, inner structure and the role of external factors such as the addition of competitive ligands have been extensively studied. MCs loaded by hydrophobic fluorescent compounds with high encapsulation efficiency demonstrate an excellent optical response in aqueous media without crystallization as well as sufficient increase in solubility of toxic hydrophobic compounds such as bilirubin ( 50 times compared to pure surfactants). Furthermore, Triton-X-based MCs provide a unique feature of selective permeability to hydrophilic ligand-switching proteins such as UnaG and BSA demonstrating bright "turn-on" fluorescence signal either inside the cluster or on its interface via complexation. The proposed strategies allowed us to successfully encapsulate and visualize a newly synthesized, highly hydrophobic anticancer PTR-58-CLB-CAMP peptide drug, while MCs loaded by the drug exhibit a considerable antitumor activity against HeLa cells.
机译:非离子表面活性剂由于其独特的物理化学性质,对各种化合物的增溶,包封,增透和控制释放引起了极大的兴趣。然而,通过保持其先进的能力以保护装载的货物而不改变其特性,来制造具有高溶解性和封装能力的便利的自组装多功能材料仍然是一项挑战。在这项工作中,我们提出了一个扩展的胶束簇(MCs)形成概念,该结构基于通过在Triton-X家族(TX-100 / TX- 114),然后通过金属离子或支持螯合剂使预形成的结构随后络合。形成方面,内部结构和外部因素(例如添加竞争性配体)的作用已得到广泛研究。由疏水性荧光化合物负载的具有高封装效率的MC在水性介质中表现出出色的光学响应,而不会结晶,并且有毒疏水性化合物(如胆红素)的溶解度充分提高(比纯表面活性剂高50倍)。此外,基于Triton-X的MC提供了对亲水性配体转换蛋白(例如UnaG和BSA)的选择性渗透性的独特功能,通过复合作用在簇内或其界面上显示出明亮的“开启”荧光信号。提出的策略使我们能够成功封装和可视化新合成的高度疏水的抗癌PTR-58-CLB-CAMP肽药物,而由该药物负载的MC对HeLa细胞表现出相当大的抗肿瘤活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号